Richard S. B. Milne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Richard S. B. Milne has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Greg Towers
Division of Infection and Immunity, University College London, London, UK
2 shared publications - Annegret Pelchen-Matthews
Department for Infection and Population Health, University College London, London, United Kingdom
1 shared publication Caroline Blondeau
University College London, Medical Research Council Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, London, United Kingdom
1 shared publication- Kate L. Morling
Wolfson Institute for Biomedical Research, University College London; London, UK, WC1E 6JL
1 shared publication - Mark Marsh
University College London
1 shared publication - Mohamed ElGhazaly
Division of Infection and Immunity, UCL, London, WC1E 6BT, UK
1 shared publication
Latest Publications
- Open Access
- 13 January 2025
- Published by Microbiology Society in Journal of General Virology
- Vol. 106 (1) , 002057
HIV capsids: orchestrators of innate immune evasion, pathogenesis and pandemicity
Human immunodeficiency virus (HIV) is an exemplar virus, still the most studied and best understood and a model for mechanisms of viral replication, immune evasion and pathogenesis. In this review, we consider the earliest stages of HIV infection from transport of the virion contents through the cytoplasm to integration of the viral genome into host chromatin. We present a holistic model for the virus–host interaction during this pivotal stage of infection. Central to this process is the HIV capsid. The last 10 years have seen a transformation in the way we understand HIV capsid structure and function. We review key discoveries and present our latest thoughts on the capsid as a dynamic regulator of innate immune evasion and chromatin targeting. We also consider the accessory proteins Vpr and Vpx because they are incorporated into particles where they collaborate with capsids to manipulate defensive cellular responses to infection. We argue that effective regulation of capsid uncoating and evasion of innate immunity define pandemic potential and viral pathogenesis, and we review how comparison of different HIV lineages can reveal what makes pandemic lentiviruses special.
- 13 January 2025
- Published by Microbiology Society in Journal of General Virology
- Vol. 106 (1) , 002057
Open AccessHIV capsids: orchestrators of innate immune evasion, pathogenesis and pandemicity
Human immunodeficiency virus (HIV) is an exemplar virus, still the most studied and best understood and a model for mechanisms of viral replication, immune evasion and pathogenesis. In this review, we consider the earliest stages of HIV infection from transport of the virion contents through the cytoplasm to integration of the viral genome into host chromatin. We present a holistic model for the virus–host interaction during this pivotal stage of infection. Central to this process is the HIV capsid. The last 10 years have seen a transformation in the way we understand HIV capsid structure and function. We review key discoveries and present our latest thoughts on the capsid as a dynamic regulator of innate immune evasion and chromatin targeting. We also consider the accessory proteins Vpr and Vpx because they are incorporated into particles where they collaborate with capsids to manipulate defensive cellular responses to infection. We argue that effective regulation of capsid uncoating and evasion of innate immunity define pandemic potential and viral pathogenesis, and we review how comparison of different HIV lineages can reveal what makes pandemic lentiviruses special.
- Open Access
- 15 December 2013
- Published by American Society for Microbiology in Journal of Virology
- Vol. 87 (24) , 13124-13133
Tetherin Restricts Herpes Simplex Virus 1 and Is Antagonized by Glycoprotein M
Tetherin is a broadly active antiviral effector that works by tethering nascent enveloped virions to a host cell membrane, thus preventing their release. In this study, we demonstrate that herpes simplex virus 1 (HSV-1) is targeted by tetherin. We identify the viral envelope glycoprotein M (gM) as having moderate anti-tetherin activity. We show that gM but not gB or gD efficiently removes tetherin from the plasma membrane and can functionally substitute for the human immunodeficiency virus type 1 (HIV-1) Vpu protein, the prototypic viral tetherin antagonist, in rescuing HIV-1 release from tetherin-expressing cells. Our data emphasize that tetherin is a broadly active antiviral effector and contribute to the emerging hypothesis that viruses must suppress or evade an array of host cell countermeasures in order to establish a productive infection.
- 15 December 2013
- Published by American Society for Microbiology in Journal of Virology
- Vol. 87 (24) , 13124-13133
Open AccessTetherin Restricts Herpes Simplex Virus 1 and Is Antagonized by Glycoprotein M
Tetherin is a broadly active antiviral effector that works by tethering nascent enveloped virions to a host cell membrane, thus preventing their release. In this study, we demonstrate that herpes simplex virus 1 (HSV-1) is targeted by tetherin. We identify the viral envelope glycoprotein M (gM) as having moderate anti-tetherin activity. We show that gM but not gB or gD efficiently removes tetherin from the plasma membrane and can functionally substitute for the human immunodeficiency virus type 1 (HIV-1) Vpu protein, the prototypic viral tetherin antagonist, in rescuing HIV-1 release from tetherin-expressing cells. Our data emphasize that tetherin is a broadly active antiviral effector and contribute to the emerging hypothesis that viruses must suppress or evade an array of host cell countermeasures in order to establish a productive infection.